EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benchmarking drug–drug interaction prediction methods: a perspective of distribution changes

Zhenqian Shen iD, Mingyang Zhou, Yongqi Zhang, Quanming Yao iD

Bioinformatics · 01.11.2025 · 41 (11)

DOI: 10.1093/bioinformatics/btaf569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformatics, online erschienen am 14.10.2025. Verfasst von Zhenqian Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical Engineering, Tsinghua University, Beijing, 100084, China. Hauptthemen laut MEDLINE: Benchmarking, Computational Biology. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangzhou Science and Technology Planning Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Motivation Emerging drug–drug interaction (DDI) prediction is crucial for new drugs but is hindered by distribution changes between known and new drugs in real-world scenarios. Current evaluation often neglects these changes, relying on unrealistic i.i.d. split due to the absence of drug approval data. Results We propose DDI-Ben, a benchmarking framework for emerging DDI prediction under distribution changes. DDI-Ben introduces a distribution change simulation framework that leverages distribution changes between drug sets as a surrogate for real-world distribution changes of DDIs, and is compatible with various drug split strategies. Through extensive benchmarking on 10 representative methods, we show that most existing approaches suffer substantial performance degradation under distribution changes. Our analysis further indicates that large language model (LLM)-based methods and the integration of drug-related textual information offer promising robustness against such degradation. To support future research, we release the benchmark datasets with simulated distribution changes. Overall, DDI-Ben highlights the importance of explicitly addressing distribution changes and provides a foundation for developing more resilient methods for emerging DDI prediction. Availability and implementation Our code and data are available at https://github.com/LARS-research/DDI-Bench.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenchmarkingComputational BiologyDrug InteractionsHumansAlgorithmsComputer Simulation

Autor:innen und Institutionen

  • Department of Electrical Engineering, Tsinghua University, Beijing, 100084, China.
  • Thrust of Data Science and Analytics, The Hong Kong University of Science and Technology (Guangzhou), Guangdong, 511453, China.
  • State Key Laboratory of Space Network and Communications, Tsinghua University, Beijing, 100084, China.

ORCID-Profile: Zhenqian Shen, Quanming Yao

Förderung

  • National Natural Science Foundation of China
  • Guangzhou Science and Technology Planning Project

Zitieren

APA

Shen, Z., Zhou, M., Zhang, Y., & Yao, Q. (2025). Benchmarking drug–drug interaction prediction methods: a perspective of distribution changes. Bioinformatics, 41(11). https://doi.org/10.1093/bioinformatics/btaf569

Vancouver

Shen Z, Zhou M, Zhang Y, Yao Q. Benchmarking drug–drug interaction prediction methods: a perspective of distribution changes. Bioinformatics. 2025;41(11). doi:10.1093/bioinformatics/btaf569

BibTeX
@article{Shen2025,
  author = {Shen, Zhenqian and Zhou, Mingyang and Zhang, Yongqi and Yao, Quanming},
  title = {Benchmarking drug–drug interaction prediction methods: a perspective of distribution changes},
  journal = {Bioinformatics},
  year = {2025},
  volume = {41},
  number = {11},
  doi = {10.1093/bioinformatics/btaf569}
}
Kostenlos starten →